New Alzheimer’s Drug, New Controversy

FDA approval of Aduhelm for early stage Alzheimer’s is both a huge breakthrough and controversy.  HealthCall’s Lee Kelso explains why this drug raises issues that affect every American family one way or the other. 

See omnystudio.com/listener for privacy information.